Therapeutic potential of NAD-boosting molecules: the in vivo evidence

L Rajman, K Chwalek, DA Sinclair - Cell metabolism, 2018 - cell.com
Nicotinamide adenine dinucleotide (NAD), the cell's hydrogen carrier for redox enzymes, is
well known for its role in redox reactions. More recently, it has emerged as a signaling …

Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis

HYF Yong, VW Yong - Nature Reviews Neurology, 2022 - nature.com
In contrast to the multiple disease-modifying therapies that are available for relapsing–
remitting multiple sclerosis (MS), the therapeutic options for progressive MS (PMS) are …

Programmed axon degeneration: from mouse to mechanism to medicine

MP Coleman, A Höke - Nature Reviews Neuroscience, 2020 - nature.com
Wallerian degeneration is a widespread mechanism of programmed axon degeneration. In
the three decades since the discovery of the Wallerian degeneration slow (Wld S) mouse …

[HTML][HTML] Nicotinamide improves aspects of healthspan, but not lifespan, in mice

SJ Mitchell, M Bernier, MA Aon, S Cortassa, EY Kim… - Cell metabolism, 2018 - cell.com
The role in longevity and healthspan of nicotinamide (NAM), the physiological precursor of
NAD+, is elusive. Here, we report that chronic NAM supplementation improves healthspan …

Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis

MA Friese, B Schattling, L Fugger - Nature Reviews Neurology, 2014 - nature.com
Multiple sclerosis (MS) is the most frequent chronic inflammatory disease of the CNS, and
imposes major burdens on young lives. Great progress has been made in understanding …

Wallerian degeneration: an emerging axon death pathway linking injury and disease

L Conforti, J Gilley, MP Coleman - Nature Reviews Neuroscience, 2014 - nature.com
Axon degeneration is a prominent early feature of most neurodegenerative disorders and
can also be induced directly by nerve injury in a process known as Wallerian degeneration …

Neurodegeneration in multiple sclerosis and neuromyelitis optica

I Kawachi, H Lassmann - Journal of Neurology, Neurosurgery & …, 2017 - jnnp.bmj.com
Multiple sclerosis (MS) and neuromyelitis optica (NMO) are autoimmune demyelinating
diseases of the central nervous system (CNS), having distinct immunological and …

NAD+/NADH and NADP+/NADPH in Cellular Functions and Cell Death: Regulation and Biological Consequences

W Ying - Antioxidants & redox signaling, 2008 - liebertpub.com
C. NADP synthesis D. Catabolism of NAD and NADP E. Relationships between NAD and
NADP F. NAD transport across mitochondrial membranes G. NAD transport across the …

Emerging therapies to target CNS pathophysiology in multiple sclerosis

J Oh, A Bar-Or - Nature Reviews Neurology, 2022 - nature.com
The rapidly evolving therapeutic landscape of multiple sclerosis (MS) has contributed to
paradigm shifts in our understanding of the biological mechanisms that contribute to CNS …

Activation of SIRT3 by the NAD+ precursor nicotinamide riboside protects from noise-induced hearing loss

KD Brown, S Maqsood, JY Huang, Y Pan, W Harkcom… - Cell metabolism, 2014 - cell.com
Intense noise exposure causes hearing loss by inducing degeneration of spiral ganglia
neurites that innervate cochlear hair cells. Nicotinamide adenine dinucleotide (NAD+) …